4.2 Review

Sphingosine-1-phosphate and oligodendrocytes: From cell development to the treatment of multiple sclerosis

Journal

PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume 91, Issue 3-4, Pages 139-144

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.prostaglandins.2009.04.002

Keywords

Oligodendrocytes; Myelination; Sphingosine-1-phosphate; FTY20

Funding

  1. Jeffress Memorial Trust
  2. National Multiple Sclerosis [RG 3432A2]

Ask authors/readers for more resources

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that mediates a wide variety of biological effects in different cells and tissues. This review discusses the effects of SIP signaling in oligodendrocytes, the myelin making cells of the central nervous system (CNS). Results from different laboratories have uncovered direct actions of S1P at different maturational stages along the oligodendroglial lineage. There is also evidence for the existence in oligodendrocytes of interactions between SIP and signaling by factors which, like neurotrophin-3 (NT-3) and platelet-derived growth factor (PDGF), have profound effects on oligodendrocyte development and myelination. Moreover, SI P signaling in oligodendrocytes may not only play an important role during normal CNS development but also offer new therapeutic avenues to stimulate remyelination in demyelinating diseases like multiple sclerosis. (C) 2009 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available